Agilent Technologies Europe — Net revenue decreased by 1.5% to $518.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from $463.00M to $518.00M. Over 4 years (FY 2021 to FY 2025), Europe — Net revenue shows an upward trend with a 3.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market penetration or stronger demand for the company's life science and diagnostic solutions in Europe, while a decrease may signal regional economic headwinds or increased competitive pressure.
This metric represents the total gross sales generated from products and services within the European geographic market....
Peers in the life sciences and diagnostics sector typically report regional revenue to highlight geographic diversification and exposure to specific regulatory or healthcare spending environments.
a_segment_europe_net_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $415.00M | $423.00M | $413.00M | $451.00M | $423.00M | $407.00M | $418.00M | $456.00M | $433.00M | $432.00M | $433.00M | $458.00M | $426.00M | $432.00M | $454.00M | $463.00M | $442.00M | $492.00M | $526.00M | $518.00M |
| QoQ Change | — | +1.9% | -2.4% | +9.2% | -6.2% | -3.8% | +2.7% | +9.1% | -5.0% | -0.2% | +0.2% | +5.8% | -7.0% | +1.4% | +5.1% | +2.0% | -4.5% | +11.3% | +6.9% | -1.5% |
| YoY Change | — | — | — | — | +1.9% | -3.8% | +1.2% | +1.1% | +2.4% | +6.1% | +3.6% | +0.4% | -1.6% | +0.0% | +4.8% | +1.1% | +3.8% | +13.9% | +15.9% | +11.9% |